Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bien E et al. – sIL–2R alpha was proven to be a promising marker for diagnosis and treatment monitoring in children with STS. It correlated also with some clinical variables known to have important prognostic role (STS stage, histological subtype and response to therapy); however, it failed to predict EFS and OS.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address